Top Suppliers:I want be here

5062-66-8

5062-66-8 structure
5062-66-8 structure
  • Name: 1-(AMINOMETHYL)CYCLOPENTANAMINE
  • Chemical Name: 1-(aminomethyl)cyclopentan-1-amine
  • CAS Number: 5062-66-8
  • Molecular Formula: C6H14N2
  • Molecular Weight: 114.18900
  • Create Date: 2018-08-15 15:33:02
  • Modify Date: 2024-01-12 19:50:15

Name 1-(aminomethyl)cyclopentan-1-amine
Synonyms Amino-1 aminomethyl-1 cyclopentane
1-aminomethyl-cyclopentylamine
1-amino-cyclopentanemethanamine
Cyclopentylamine,1-aminomethyl
1-Amino-1-aminomethyl-cyclopentan
Density 0.955g/cm3
Boiling Point 158.5ºC at 760 mmHg
Molecular Formula C6H14N2
Molecular Weight 114.18900
Flash Point 55.3ºC
Exact Mass 114.11600
PSA 52.04000
LogP 1.61720
Index of Refraction 1.493

CHEMICAL IDENTIFICATION

RTECS NUMBER :
GY8455000
CHEMICAL NAME :
Cyclopentylamine, 1-aminomethyl-
CAS REGISTRY NUMBER :
5062-66-8
LAST UPDATED :
199712
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C6-H14-N2
MOLECULAR WEIGHT :
114.22
WISWESSER LINE NOTATION :
L5TJ AZ AM1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
240 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
CHTPBA Chimica Therapeutica. (Paris, France) V.1-8, 1965-73. For publisher information, see EJMCA5. Volume(issue)/page/year: 4,136,1969
HS Code 2921300090

~75%

5062-66-8 structure

5062-66-8

Literature: SANOFI; Arigon, Jerome; Brollo, Maurice; Clement, Jacques; Combet, Romain; Durand, Florence; El Ahmad, Youssef; Labrosse, Jean-Robert; Letallec, Jean-Philippe; Ronan, Baptiste Patent: US2013/289031 A1, 2013 ; Location in patent: Paragraph 0363-0364 ;

~13%

5062-66-8 structure

5062-66-8

Literature: Sanwa Kagaku Kenkyusho Co., Ltd. Patent: JP2005/298495 A, 2005 ; Location in patent: Page/Page column 6-7 ;

~%

5062-66-8 structure

5062-66-8

Literature: Novartis AG Patent: US2010/130506 A1, 2010 ; Location in patent: Page/Page column 110 ;

~%

5062-66-8 structure

5062-66-8

Literature: Vertex Pharmaceuticals Incorported Patent: US2011/98311 A1, 2011 ;

~%

5062-66-8 structure

5062-66-8

Literature: Vertex Pharmaceuticals Incorported Patent: US2011/98311 A1, 2011 ;

~%

5062-66-8 structure

5062-66-8

Literature: SANOFI; Arigon, Jerome; Brollo, Maurice; Clement, Jacques; Combet, Romain; Durand, Florence; El Ahmad, Youssef; Labrosse, Jean-Robert; Letallec, Jean-Philippe; Ronan, Baptiste Patent: US2013/289031 A1, 2013 ;

~%

5062-66-8 structure

5062-66-8

Literature: SANOFI; Arigon, Jerome; Brollo, Maurice; Clement, Jacques; Combet, Romain; Durand, Florence; El Ahmad, Youssef; Labrosse, Jean-Robert; Letallec, Jean-Philippe; Ronan, Baptiste Patent: US2013/289031 A1, 2013 ;

~%

5062-66-8 structure

5062-66-8

Literature: Granger,R.; Techer,H. Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1960 , vol. 250, p. 2581 - 2583
HS Code 2921300090
Summary 2921300090 other cyclanic, cyclenic or cyclotherpenic mono- or polyamines, and their derivatives; salts thereof。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0%